Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03196492 · ClinicalTrials.gov registry record
Vaginal Microbiota, and STI/HIV Risk Among Adolescent Girls and Young Women
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 234
- Enrollment target
NCT03196492: Completed study, sponsored by Johns Hopkins University.
NCT03196492 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 234 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03196492 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 234 participants
- Enrollment target
Study Summary
The investigators are doing a study on the bacteria that normally live in the vagina and what effect, if any, Depo-Provera has on the bacteria. Women 13-24 years of age, who are HIV negative, being seen in a clinic for birth control or sexually transmitted disease (STD) check-up, or have a child and are planning to receive a Depo-Provera shot for contraception or have declined the use of hormonal contraception may join.
Primary Outcome
The investigators will determine if there is an association between lactobacillus-dominant microbiota and STIs. The investigators will report the prevalence of each vaginal community state types (CST) and STIs.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 234 participants |
| Start Date | 2017-06-14 |
| Est. Completion | 2021-06-14 |
What the finished NCT03196492 record still lists
NCT03196492 is an observational study that tracks outcomes without assigning an intervention. The registered 234 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT03196492 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03196492 about?
NCT03196492 is a clinical study titled "Vaginal Microbiota, and STI/HIV Risk Among Adolescent Girls and Young Women". The investigators are doing a study on the bacteria that normally live in the vagina and what effect, if any, Depo-Provera has on the bacteria. Women 13-24 years of age, who are HIV negative, being seen in a clinic for birth control or sexually transmitted disease (STD) check-up, or have a child an...
What is the current status of trial NCT03196492?
This trial is currently completed. The enrollment target is 234 participants. The study started on 2017-06-14. Estimated completion is 2021-06-14.
What interventions are being tested in trial NCT03196492?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT03196492?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04942717 · 234 participants · NA
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values
- NCT05208671 · 234 participants · NA
Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma
- NCT05444465 · 234 participants · NA
Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears
- NCT05720338 · 234 participants · Phase 3
Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI